Go Deep
J-Pharma Co., Ltd.
J-Pharma Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,199 | -5.0 | 3.44 | 0.00 | 271.81 |
J-Pharma Co., Ltd. Quarterly Results
| Line Item | Dec 2025 |
|---|---|
| Revenue | 0.0 |
| Net Profit | -447,927,000.0 |
J-Pharma Co., Ltd. Revenue & Profit: Last 2 Years
| Line Item | Mar 2025 | Mar 2024 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -1,499,008,000.0 | -1,652,337,000.0 |
| EPS | — | -92.7 |
J-Pharma Co., Ltd. Balance Sheet
| Line Item | Mar 2025 | Mar 2024 |
|---|---|---|
| Total Assets | 2,856,719,000.0 | 1,207,393,000.0 |
| Total Liabilities | 478,850,000.0 | 257,270,000.0 |
| Total Equity | 2,377,869,000.0 | 950,123,000.0 |
Owes vs Owns
J-Pharma Co., Ltd. owed ¥0.21 for every ¥1 it owned in Dec 2025, down from ¥0.21 in Mar 2024.
| Period | Dec 2025 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Owes vs Owns | 0.21× | 0.17× | 0.21× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
J-Pharma Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2025
Cash & short-term investments 80.6%Long-term investments 0.5%Other assets 18.9%
How it's funded — Mar 2025
Payables 5.4%Other liabilities 11.4%Shareholders' equity 83.2%
| Line Item | Mar 2025 | Mar 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 2,301.9 | 1,073.2 |
| Receivables | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 15.0 | 15.0 |
| Other assets | 539.9 | 119.3 |
| Liabilities & equity | ||
| Short-term debt | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 |
| Payables | 153.0 | 146.8 |
| Other liabilities | 325.9 | 110.5 |
| Shareholders' equity | 2,377.9 | 950.1 |
| Net tangible assets | 2,377.9 | 950.1 |
J-Pharma Co., Ltd. Cash Flow
| Line Item | Mar 2025 | Mar 2024 |
|---|---|---|
| Operating Activities | -1,694,864,000.0 | -1,411,304,000.0 |
| Investing Activities | -191,000.0 | -29,713,000.0 |
| Financing Activities | 2,924,000,000.0 | 925,000,000.0 |